Please enable JavaScript to continue using this application.

Compare $JANX vs $MGTX | Chartloom

Compare

$JANX vs $MGTX

Janux Therapeutics Inc · MeiraGTx Holdings PLC

JANX

Janux Therapeutics Inc

MGTX

MeiraGTx Holdings PLC

Compare $JANX vs $MGTX

Comparing Janux Therapeutics Inc and MeiraGTx Holdings PLC

JANXJanux Therapeutics Inc

MGTXMeiraGTx Holdings PLC

JANXJanux Therapeutics Inc

Market cap

$1.12B

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

63.26x

Rev growth (TTM)

5367.0%

YTD performance

34.7%

52W performance

-24.0%

FCF yield

-3.7%

MGTXMeiraGTx Holdings PLC

Market cap

$990M

P/E (TTM)

12.70x

Forward P/E (NTM)

—

Forward P/S (NTM)

27.71x

Rev growth (TTM)

948.3%

YTD performance

36.9%

52W performance

29.4%

FCF yield

1.1%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

JANX

MGTX

Detailed metrics comparison

JANX

Janux Therapeutics Inc

MGTX

MeiraGTx Holdings PLC

Market Cap

JANX$1.12B

MGTX$990M

Enterprise Value

JANX$1.09B

MGTX$947M

Price

JANX$18.39

MGTX$10.69

P/E Ratio

JANXN/A

MGTX12.70x

P/S Ratio

JANX46.73x

MGTX2.49x

EV/Sales

JANX45.57x

MGTX2.38x

EV/EBITDA

JANX0.00x

MGTX4.63x

P/B Ratio

JANX1.12x

MGTX4.81x

P/FCF Ratio

JANXN/A

MGTX94.58x

EV/FCF

JANX-26.09x

MGTX90.47x

PEG Ratio

JANXN/A

MGTXN/A

Forward P/E (NTM)

JANXN/A

MGTXN/A

Forward P/S (NTM)

JANX63.26x

MGTX27.71x

Revenue (TTM)

JANX$24M

MGTX$398M

Revenue Growth (YoY)

JANX5367.0%

MGTX948.3%

Forward Rev Growth

JANX-76.0%

MGTX-75.7%

Gross Margin (TTM)

JANX0.0%

MGTX97.9%

Operating Margin (TTM)

JANX0.0%

MGTX46.3%

EBITDA Margin (TTM)

JANX-590.2%

MGTX49.3%

Net Margin (TTM)

JANX-427.5%

MGTX19.9%

FCF Margin (TTM)

JANX-174.7%

MGTX2.6%

Net Income (TTM)

JANX$-103M

MGTX$79M

FCF (TTM)

JANX$-42M

MGTX$10M

EPS (TTM)

JANX-$1.63

MGTX$0.84

ROE (TTM)

JANX-1079.0%

MGTX74.6%

ROA (TTM)

JANX-1010.0%

MGTX29.4%

ROIC (TTM)

JANX-1079.0%

MGTX50.9%

Cash

JANX$28M

MGTX$143M

Debt

JANX$0

MGTX$100M

Net Cash/Debt

JANX$28M

MGTX$43M

Current Ratio (TTM)

JANX16.35x

MGTX3.76x

Quick Ratio (TTM)

JANX16.25x

MGTX3.69x

Debt/Equity (TTM)

JANX0.00x

MGTX0.46x

Debt/Assets (TTM)

JANX0.0%

MGTX0.0%

Interest Coverage (TTM)

JANXN/A

MGTXN/A

Net Debt/EBITDA (TTM)

JANX0.00x

MGTX0.00x

Beta

JANX2.42

MGTX1.05

52W Performance

JANX-24.0%

MGTX29.4%

YTD Performance

JANX34.7%

MGTX36.9%

% from 52W High

JANX-48.0%

MGTX-30.4%

% from 52W Low

JANX51.7%

MGTX61.5%

Asset Turnover (TTM)

JANX0.02x

MGTX1.48x

FCF Yield (TTM)

JANX-3.7%

MGTX1.1%

Earnings Yield (TTM)

JANX-9.1%

MGTX8.0%

Dividend Yield (TTM)

JANXN/A

MGTXN/A

Rule of 40

JANX5,192.3

MGTX951.0

EV/GP/RG

JANXN/A

MGTXN/A

Ticker research

View JANX research View MGTX research

Metric	JANX Janux Therapeutics Inc	MGTX MeiraGTx Holdings PLC
Market & Valuation
Market Cap	$1.12B	$990M
Enterprise Value	$1.09B	$947M
Price	$18.39	$10.69
P/E Ratio	N/A	12.70x
P/S Ratio	46.73x	2.49x
EV/Sales	45.57x	2.38x
EV/EBITDA	0.00x	4.63x
P/B Ratio	1.12x	4.81x
P/FCF Ratio	N/A	94.58x
EV/FCF	-26.09x	90.47x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	63.26x	27.71x
Revenue & Growth
Revenue (TTM)	$24M	$398M
Revenue Growth (YoY)	5367.0%	948.3%
Forward Rev Growth	-76.0%	-75.7%
Profitability
Gross Margin (TTM)	0.0%	97.9%
Operating Margin (TTM)	0.0%	46.3%
EBITDA Margin (TTM)	-590.2%	49.3%
Net Margin (TTM)	-427.5%	19.9%
FCF Margin (TTM)	-174.7%	2.6%
Net Income (TTM)	$-103M	$79M
FCF (TTM)	$-42M	$10M
EPS (TTM)	-$1.63	$0.84
ROE (TTM)	-1079.0%	74.6%
ROA (TTM)	-1010.0%	29.4%
ROIC (TTM)	-1079.0%	50.9%
Financial Health
Cash	$28M	$143M
Debt	$0	$100M
Net Cash/Debt	$28M	$43M
Current Ratio (TTM)	16.35x	3.76x
Quick Ratio (TTM)	16.25x	3.69x
Debt/Equity (TTM)	0.00x	0.46x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	2.42	1.05
52W Performance	-24.0%	29.4%
YTD Performance	34.7%	36.9%
% from 52W High	-48.0%	-30.4%
% from 52W Low	51.7%	61.5%
Efficiency & Yields
Asset Turnover (TTM)	0.02x	1.48x
FCF Yield (TTM)	-3.7%	1.1%
Earnings Yield (TTM)	-9.1%	8.0%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	5,192.3	951.0
EV/GP/RG	N/A	N/A
Ticker research	View JANX research	View MGTX research

Valuation

P/E Ratio

MGTX

12.70x

P/S Ratio

MGTX

2.49x

JANX

46.73x

EV/FCF

JANX

-26.09x

MGTX

90.47x

Growth & revenue

Revenue Growth TTM

JANX

5367.0%

MGTX

948.3%

Forward Revenue Growth

MGTX

-75.7%

JANX

-76.0%

Profitability & performance

Gross Margin

MGTX

97.9%

JANX

0.0%

ROE

MGTX

74.6%

JANX

-1079.0%

FCF Yield %

MGTX

1.1%

JANX

-3.7%

52-Week Performance

MGTX

29.4%

JANX

-24.0%

Detailed metrics comparison

JANX

Janux Therapeutics Inc

MGTX

MeiraGTx Holdings PLC

Market Cap

JANX$1.12B

MGTX$990M

Enterprise Value

JANX$1.09B

MGTX$947M

Price

JANX$18.39

MGTX$10.69

P/E Ratio

JANXN/A

MGTX12.70x

P/S Ratio

JANX46.73x

MGTX2.49x

EV/Sales

JANX45.57x

MGTX2.38x

EV/EBITDA

JANX0.00x

MGTX4.63x

P/B Ratio

JANX1.12x

MGTX4.81x

P/FCF Ratio

JANXN/A

MGTX94.58x

EV/FCF

JANX-26.09x

MGTX90.47x

PEG Ratio

JANXN/A

MGTXN/A

Forward P/E (NTM)

JANXN/A

MGTXN/A

Forward P/S (NTM)

JANX63.26x

MGTX27.71x

Revenue (TTM)

JANX$24M

MGTX$398M

Revenue Growth (YoY)

JANX5367.0%

MGTX948.3%

Forward Rev Growth

JANX-76.0%

MGTX-75.7%

Gross Margin (TTM)

JANX0.0%

MGTX97.9%

Operating Margin (TTM)

JANX0.0%

MGTX46.3%

EBITDA Margin (TTM)

JANX-590.2%

MGTX49.3%

Net Margin (TTM)

JANX-427.5%

MGTX19.9%

FCF Margin (TTM)

JANX-174.7%

MGTX2.6%

Net Income (TTM)

JANX$-103M

MGTX$79M

FCF (TTM)

JANX$-42M

MGTX$10M

EPS (TTM)

JANX-$1.63

MGTX$0.84

ROE (TTM)

JANX-1079.0%

MGTX74.6%

ROA (TTM)

JANX-1010.0%

MGTX29.4%

ROIC (TTM)

JANX-1079.0%

MGTX50.9%

Cash

JANX$28M

MGTX$143M

Debt

JANX$0

MGTX$100M

Net Cash/Debt

JANX$28M

MGTX$43M

Current Ratio (TTM)

JANX16.35x

MGTX3.76x

Quick Ratio (TTM)

JANX16.25x

MGTX3.69x

Debt/Equity (TTM)

JANX0.00x

MGTX0.46x

Debt/Assets (TTM)

JANX0.0%

MGTX0.0%

Interest Coverage (TTM)

JANXN/A

MGTXN/A

Net Debt/EBITDA (TTM)

JANX0.00x

MGTX0.00x

Beta

JANX2.42

MGTX1.05

52W Performance

JANX-24.0%

MGTX29.4%

YTD Performance

JANX34.7%

MGTX36.9%

% from 52W High

JANX-48.0%

MGTX-30.4%

% from 52W Low

JANX51.7%

MGTX61.5%

Asset Turnover (TTM)

JANX0.02x

MGTX1.48x

FCF Yield (TTM)

JANX-3.7%

MGTX1.1%

Earnings Yield (TTM)

JANX-9.1%

MGTX8.0%

Dividend Yield (TTM)

JANXN/A

MGTXN/A

Rule of 40

JANX5,192.3

MGTX951.0

EV/GP/RG

JANXN/A

MGTXN/A

Ticker research

View JANX research View MGTX research

Metric	JANX Janux Therapeutics Inc	MGTX MeiraGTx Holdings PLC
Market & Valuation
Market Cap	$1.12B	$990M
Enterprise Value	$1.09B	$947M
Price	$18.39	$10.69
P/E Ratio	N/A	12.70x
P/S Ratio	46.73x	2.49x
EV/Sales	45.57x	2.38x
EV/EBITDA	0.00x	4.63x
P/B Ratio	1.12x	4.81x
P/FCF Ratio	N/A	94.58x
EV/FCF	-26.09x	90.47x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	63.26x	27.71x
Revenue & Growth
Revenue (TTM)	$24M	$398M
Revenue Growth (YoY)	5367.0%	948.3%
Forward Rev Growth	-76.0%	-75.7%
Profitability
Gross Margin (TTM)	0.0%	97.9%
Operating Margin (TTM)	0.0%	46.3%
EBITDA Margin (TTM)	-590.2%	49.3%
Net Margin (TTM)	-427.5%	19.9%
FCF Margin (TTM)	-174.7%	2.6%
Net Income (TTM)	$-103M	$79M
FCF (TTM)	$-42M	$10M
EPS (TTM)	-$1.63	$0.84
ROE (TTM)	-1079.0%	74.6%
ROA (TTM)	-1010.0%	29.4%
ROIC (TTM)	-1079.0%	50.9%
Financial Health
Cash	$28M	$143M
Debt	$0	$100M
Net Cash/Debt	$28M	$43M
Current Ratio (TTM)	16.35x	3.76x
Quick Ratio (TTM)	16.25x	3.69x
Debt/Equity (TTM)	0.00x	0.46x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	2.42	1.05
52W Performance	-24.0%	29.4%
YTD Performance	34.7%	36.9%
% from 52W High	-48.0%	-30.4%
% from 52W Low	51.7%	61.5%
Efficiency & Yields
Asset Turnover (TTM)	0.02x	1.48x
FCF Yield (TTM)	-3.7%	1.1%
Earnings Yield (TTM)	-9.1%	8.0%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	5,192.3	951.0
EV/GP/RG	N/A	N/A
Ticker research	View JANX research	View MGTX research